By Nicholas Megaw – Fianacial Times –
Biotech companies are rushing to raise money in US equity markets at the fastest rate since the peak of the mid-pandemic market boom.
Drug developers raised $6.2bn in equity capital markets in January, according to data from Jefferies. That marked the largest total since February 2021, the same month that the most popular tracker of biotech stocks hit its all-time high.
